Covid-19: Covishield, Covaxin dose likely to be capped at Rs 27527 Jan, 2022, 11.14 AM ISTDr Reddy's Lab will come out with the pricing and roll-out of anti-covid drug 2-DG in a few days: Dr Sudhir Chandna, DRDO09 May, 2021, 07.55 PM ISTFPIs pump record Rs 39,640 crore into Indian G-Secs in June so far
Cooling crude prices drive weekly gains; Street expects Q2 earnings recovery
JPMorgan puts two more in line to succeed Jamie Dimon
Vedanta Resources buyback offer gets $943 million bond bids
Hybrid SIFs lure wealthy investors with tax edge and stronger returns
Tata Chemicals surges on Tata Sons listing buzz
Short positions in G-Secs on cards to improve liquidity
AI levels the playing field as IT giants target mid-market game
Cheaper crude and Strait of Hormuz reopening boost outlook for Indian refiners
No vacancy at home: Worsening job market greets H-1B returnees
Living on borrowed AI won’t end well for India, warn experts
VCs pivot to EV infra & energy storage in new $65 million funding wave
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service